Tuesday, January 21, 2014    |    
Bio-IT World    |    Archives    |    Advertising   |    CHI Conferences    |    Subscribe

 

Acquired by IBM, Aspera Pushes On To the Science DMZ [Bio-IT World]

Ingenuity to be Rebranded QIAGEN [Bio-IT World News Brief]

What You Need to Know About Illumina's New Sequencers [Bio-IT World]  

 

JP Morgan and the Innovation Landscape [Xconomy]

Catching Rare Disorders in the First Months of Life [Bloomberg]

FDA, 23andMe, and the Democratization of Healthcare [Nature]

Merck's Plans for Chemists, the FDA, and Upcoming Deals [Forbes]